We hypothesized that co-targeting IKZF3 and BRD9 might enchance growth suppression of naïve and drug-resistant MM cells since each approach leads to the downregulation of MYC [7,8,9,26]. This evidence concerns the gene IKZF3 and Miyoshi myopathy.